北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01228 北海康成-B

休市中 04-10 16:05:14

2.720

-0.020

-0.73%

最高2.790	最低2.670	成交量50.30万
今开2.740	昨收2.740	日振幅4.38%
总市值16.18亿	流通市值16.18亿	总股本5.95亿
成交额136.51万	换手率0.08%	流通股本5.95亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01228","market":"HK","secType":"STK","nameCN":"北海康成-B","latestPrice":2.72,"timestamp":1775808314837,"preClose":2.74,"halted":0,"volume":503000,"delay":0,"changeRate":-0.0072992700729927066,"floatShares":595000000,"shares":595000000,"eps":0.034385005795920916,"marketStatus":"休市中","change":-0.02,"latestTime":"04-10 16:05:14","open":2.74,"high":2.79,"low":2.67,"amount":1365130,"amplitude":0.043796,"askPrice":2.7,"askSize":16000,"bidPrice":2.67,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.03209267207619286,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":7,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":2.74,"openAndCloseTimeList":[[1775784600000,1775793600000],[1775797200000,1775808000000]],"volumeRatio":0.4125656167471417,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01228","defaultTab":"news","newsList":[{"id":"1103927872","title":"北海康成-B2026年2月股份变动月报：新增发行3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1103927872","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103927872?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:51","pubTimestamp":1775724689,"startTime":"0","endTime":"0","summary":"北海康成製藥有限公司于2026年4月9日公布2026年2月股份变动月报。报告期为2026年2月1日至2026年2月28日。于本月末，公司已发行普通股数量为511,252,234股，较上月底增加30,000股。根据月报披露，上述股份增发主要来自“首次公开发售后购股权计划”的期权行使，当月行使期权产生30,000股新增发行，获得认购资金约80,400港元。报告期内，没有购回、注销或库藏股变动情形。截至2026年2月底，公司公众持股量符合香港联交所相关规定，股本规模相对保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178704097","title":"北海康成-B3月股份变动月报：股本增至5.95亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1178704097","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178704097?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:50","pubTimestamp":1775724650,"startTime":"0","endTime":"0","summary":"北海康成製藥有限公司于2026年4月9日发布3月股份变动月报表。报告期为截至2026年3月31日。公司法定股本维持5,000,000,000股，面值每股0.00001美元，注册股本总额50,000美元，与上月底无变化。报告期内已发行股份从上月底的511,252,234股增至595,443,347股，新增发行84,191,113股。本月底公司无库藏股，无购回或注销股份记录。月报显示，截至2026年3月31日，公司已满足香港联交所的相关公众持股量要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132196492","title":"北海康成更新1月股份变动月报表，股本增至511,222,234股","url":"https://stock-news.laohu8.com/highlight/detail?id=1132196492","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132196492?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:47","pubTimestamp":1775724449,"startTime":"0","endTime":"0","summary":"北海康成製藥有限公司于2026年4月9日发布截至2026年1月31日的股份变动月报表。公告显示，公司本月注册股本维持不变，法定股本依旧为50,000美元，总股数上限为5,000,000,000股。本月已发行股份由上月底的511,120,234股增至511,222,234股，新增102,000股。公司在报告期内未发生库藏股、回购及注销事宜。此外，公告说明公司另有首次公开发售前股权激励计划及首次公开发售后受限制股份单位计划，但本月未有新股发行及转让事宜。截至报告期末，北海康成的股本数量为511,222,234股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177582806","title":"北海康成-B更新2025年11月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1177582806","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177582806?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:47","pubTimestamp":1775724433,"startTime":"0","endTime":"0","summary":"北海康成制药有限公司于2026年4月9日公布2025年11月股份变动月报。报告期截至2025年11月30日，公司法定股本维持在5,000,000,000股普通股，总额USD50,000，与上月一致。期末已发行股份数为510,826,484股，较上月无变化，库存股份数为0。报告期内公司未发生任何新增发行、购回或注销股份行为。若全部行使，可影响已发行股份28,245,342股。此外，“首次公开发售前股权激励计划”下可发行21,858,960股，本月无变动。公司同时确认满足香港联交所相关上市规则的公众持股量要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153467582","title":"北海康成-B更新2025年12月股份变动月报表，股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1153467582","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153467582?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:47","pubTimestamp":1775724422,"startTime":"0","endTime":"0","summary":"北海康成製藥有限公司（股票代码：01228）于2026年4月9日发布2025年12月股份变动月报表。公告显示，公司法定股本保持USD 50,000不变；截至2025年12月31日，已发行普通股由上月底的510,826,484股增至511,120,234股，单月新增293,750股。\n其中，首次公开发售后购股权计划在报告期内行使93,750股，募资金额为HKD 99,037.5；同时，首次公开发售前股权激励计划当月发行200,000股。报告期内无任何购回或注销行为，库藏股数目维持为0。截至月末，公司已确认满足香港联交所上市规则的公众持股量要求。公告由董事长薛群博士签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189362957","title":"北海康成-B更新10月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1189362957","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189362957?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:42","pubTimestamp":1775724170,"startTime":"0","endTime":"0","summary":"北海康成製藥有限公司于2026年4月9日发布截至2025年10月31日的股份变动月报表。报告显示，公司本月内无新增发行或回购活动，整体股本情况保持稳定。公司经公告确认，截至10月底，其法定注册股本维持在5,000,000,000股普通股，面值为每股USD 0.00001，法定注册股本总额继续为USD 50,000。公司于月报中再度确认其已达到适用的公眾持股量要求。至此，公司截至10月底的股本维持在510,826,484股，未发生任何购回或注销行为。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170862215","title":"北海康成-B更新9月股份变动月报表，已发行股份增至510,826,484股","url":"https://stock-news.laohu8.com/highlight/detail?id=1170862215","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170862215?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:42","pubTimestamp":1775724122,"startTime":"0","endTime":"0","summary":"北海康成制药有限公司于2026年4月9日发布截至2025年9月30日的股份变动月报表。报告期内公司法定股本维持每股面值0.00001美元、共5,000,000,000股，注册股本总额保持在50,000美元。报告期初公司已发行股份为499,809,788股，期内新增发行股份11,016,696股，报告期末已发行股份总数增至510,826,484股。有关股份期权中，本月内186,000股期权已失效，另外在报告期内行使的购股权筹得现金约546,205港元。公司表示，目前已遵守香港联交所的最低公众持股量要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162693704","title":"异动解读 | 北海康成-B(01228)盘中大涨5.32%，因2025年度业绩扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1162693704","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162693704?lang=zh_cn&edition=full","pubTime":"2026-03-31 16:02","pubTimestamp":1774944174,"startTime":"0","endTime":"0","summary":"北海康成-B(01228)今日盘中股价大幅上涨5.32%，引起了市场关注。消息面上，公司公布了截至2025年12月31日止的年度业绩，成功实现扭亏为盈。根据公告，公司股东应占溢利为1481.8万元人民币，而上年同期为亏损4.43亿元人民币，每股盈利0.03元人民币，公司决定不派息。尽管全年收入同比下降41.2%至5000万元人民币，但盈利能力的显著改善被视为推动股价上涨的关键因素。此次业绩逆转标志着公司经营状况的积极变化，增强了投资者对公司未来发展的信心，从而在交易时段内提振了股价。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623732219","title":"北海康成-B(01228)：练少娥获委任为法律程序文件代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2623732219","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623732219?lang=zh_cn&edition=full","pubTime":"2026-03-31 06:27","pubTimestamp":1774909670,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B 发布公告，公司之联席公司秘书之一黄伟超先生(黄先生)已提出辞任本公司联席公司秘书职务。于黄先生辞任后，马女士亦已获委任为授权代表之一，以取代其职务，自2026年3月30日起生效;及于黄先生辞任后，练少娥女士(练女士)已获委任为法律程序文件代理人，以取代其职务，自 2026年3月30日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623287383","title":"北海康成-B(01228)发布年度业绩 净利润1481.8万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2623287383","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623287383?lang=zh_cn&edition=full","pubTime":"2026-03-31 01:53","pubTimestamp":1774893195,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)发布截至2025年12月31日止年度全年业绩，集团收益人民币4998.3万元，同比减少41.27%;净利润1481.8万元，同比扭亏为盈;每股盈利0.03元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619650261","title":"港股异动 | 北海康成-B(01228)午后涨超4% 公司完成向药明生物子公司配售股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619650261","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619650261?lang=zh_cn&edition=full","pubTime":"2026-03-13 14:42","pubTimestamp":1773384153,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B(01228)午后涨超4%，截至发稿，涨4%，报2.6港元，成交额159.38万港元。消息面上，北海康成完成发行合共8403.36万股认购股份。公司此前宣布，向药明生物旗下子公司配售股份。配售完成后，药明生物于北海康成的持股比例将升至约16.27%。公告称，配股事项所得款项净额约1.99亿港元，约12%将用于商业化产品的营运资金及注册维护；28%用于现有产品线的研发开支；60%用于结算集团的贸易应付款项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0043850808.USD","LU0979878070.USD","SG9999002463.SGD","LU0039217434.USD","LU0456846285.SGD","BK4585","LU0516422440.USD","LU0516423091.SGD","LU0307460666.USD","SG9999002562.SGD","LU0052750758.USD","LU0516422952.EUR","LU0320764599.SGD","VXUS","LU1880383366.USD","LU0516422366.SGD","LU0051755006.USD","LU1242518857.USD","LU1242518931.SGD","IE00B0JY6N72.USD","LU0417516738.SGD","LU0823426308.USD","BK1521","LU0417516902.SGD","BK1576","LU0359201612.USD","LU0819121731.USD","LU0348735423.USD","BK1589","LU0359202008.SGD","LU0588546209.SGD","BK1610","LU0516423174.USD","LU0326950275.SGD","LU0856984785.SGD","LU2039709279.SGD","BK1141","LU0456827905.SGD","BK1161","LU1688375341.USD","02269","01228","LU0181495838.USD","LU0348825331.USD","LU0572944931.SGD","LU0140636845.USD","LU1794554557.SGD","LU0823426480.USD","LU0327786744.USD","LU3063872942.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618962638","title":"北海康成-B(01228)完成发行合共8403.36万股认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2618962638","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618962638?lang=zh_cn&edition=full","pubTime":"2026-03-11 06:16","pubTimestamp":1773180970,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)发布公告，认购协议所载条件已获达成，并已根据认购协议的条款及条件于2026年3月10日完成交割。公司于交割日期以认购价每股认购股份2.38港元向认购人配发及发行合共8403.36万股认购股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618664521","title":"北海康成-B盘中异动 大幅下跌6.99%报2.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618664521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618664521?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:40","pubTimestamp":1773020430,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时40分，北海康成-B股票出现异动，股价急速下跌6.99%。截至发稿，该股报2.530港元/股，成交量48.1万股，换手率0.09%，振幅5.88%。资金方面，该股资金流入37.151万港元，流出67.374万港元。北海康成-B股票所在的生物技术行业中，整体跌幅为3.19%。其相关个股中，科济药业-B、维立志博-B、愉悦集团涨幅较大，振幅较大的相关个股有科济药业-B、派格生物医药-B、维立志博-B，振幅分别为30.36%、15.64%、12.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909403095458e84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909403095458e84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187944501","title":"北海康成-B（01228）更新2月股份变动月报表，股本增至511,252,234股","url":"https://stock-news.laohu8.com/highlight/detail?id=1187944501","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187944501?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:41","pubTimestamp":1772700100,"startTime":"0","endTime":"0","summary":"北海康成-B于2026年3月5日发布截至2026年2月28日的股份变动月报表。公司法定股本保持在5,000,000,000股，面值每股0.00001美元，总额50,000美元，本月并无变动。本月公司已发行股份由上月底的511,222,234股增至511,252,234股，新增30,000股，均由行使首次公开发售后购股权计划产生，合计募集资金约80,400港元。截至报告期末，公司已发行股份总数为511,252,234股，公众持股量符合香港联交所相关规定。公司表示将继续遵守香港联交所《上市规则》等相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617592355","title":"北海康成-B03月04日获主力加仓271.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617592355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617592355?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612135,"startTime":"0","endTime":"0","summary":"03月04日, 北海康成-B股价涨1.48%，报收2.74元，成交金额500.9万元，换手率0.37%，振幅3.33%，量比1.07。北海康成-B今日主力资金净流入271.2万元，上一交易日主力净流入54万元。该股近5个交易日下跌1.79%，主力资金累计净流入435.1万元；近20日主力资金累计净流入830.8万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161726a6a13bed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161726a6a13bed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616879397","title":"北海康成-B盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616879397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616879397?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:45","pubTimestamp":1772502358,"startTime":"0","endTime":"0","summary":"2026年03月03日早盘09时45分，北海康成-B股票出现波动，股价大幅跳水5.24%。截至发稿，该股报2.710港元/股，成交量16.7万股，换手率0.03%，振幅2.45%。资金方面，该股资金流入0港元，流出45.671万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中，整体涨幅为0.67%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030309455897a7bb1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030309455897a7bb1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614316998","title":"北海康成-B盘中异动 股价大涨5.34%报2.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614316998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614316998?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:46","pubTimestamp":1772156797,"startTime":"0","endTime":"0","summary":"2026年02月27日早盘09时46分，北海康成-B股票出现波动，股价急速上涨5.34%。截至发稿，该股报2.960港元/股，成交量14.4万股，换手率0.03%，振幅2.85%。资金方面，该股资金流入16.211万港元，流出23.405万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中，整体涨幅为0.48%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709463795422c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709463795422c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614708649","title":"北海康成-B午后一度涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614708649","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614708649?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:53","pubTimestamp":1772002422,"startTime":"0","endTime":"0","summary":"每经AI快讯，北海康成-B(01228.HK)午后一度涨超6%，截至发稿涨5.68%，报2.79港元，成交额172.27万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602253653975683.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602253653975683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01228","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614770941","title":"港股异动 | 北海康成-B(01228)午后涨超6% 拟向药明生物子公司配股 净筹约1.99亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614770941","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614770941?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:36","pubTimestamp":1772001366,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B(01228)午后涨超6%，截至发稿，涨5.68%，报2.79港元，成交额172.27万港元。消息面上，北海康成此前宣布，向药明生物旗下子公司配售8,403.36万股股份，占扩大后股本约14.12%。配股事项所得款项净额约1.99亿港元，约12%将用于商业化产品的营运资金及注册维护；28%用于现有产品线的研发开支；60%用于结算集团的贸易应付款项。配售完成后，药明生物于北海康成的持股比例将升至约16.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2039709279.SGD","BK4585","02269","BK1576","LU0823426480.USD","LU1242518857.USD","LU1720050803.USD","LU0588546209.SGD","LU0320764599.SGD","LU0043850808.USD","LU0348825331.USD","LU0348735423.USD","BK1141","LU0516422952.EUR","LU1880383366.USD","VXUS","LU0359201612.USD","VT","LU0327786744.USD","LU0417516902.SGD","LU0359202008.SGD","LU0516422440.USD","LU0823426308.USD","LU0051755006.USD","BK1521","01228","BK1589","LU0417516738.SGD","LU0516422366.SGD","LU0856984785.SGD","LU0979878070.USD","IE00B0JY6N72.USD","BK1610","LU0572944931.SGD","BK4588","LU1794554557.SGD","SG9999002463.SGD","BK1161","LU0039217434.USD","LU0456846285.SGD","LU1688375341.USD","LU0181495838.USD","LU0456827905.SGD","LU0140636845.USD","LU0052750758.USD","LU1242518931.SGD","LU0516423174.USD","SG9999002562.SGD","LU0326950275.SGD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614086494","title":"北海康成-B盘中异动 早盘急速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614086494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614086494?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:47","pubTimestamp":1771984056,"startTime":"0","endTime":"0","summary":"2026年02月25日早盘09时47分，北海康成-B股票出现异动，股价快速上涨5.30%。截至发稿，该股报2.780港元/股，成交量5.7万股，换手率0.01%，振幅5.30%。北海康成-B股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，北海康成-B、翰思艾泰-B、创胜集团-B涨幅较大，振幅较大的相关个股有云康集团、帝王国际投资、百奥赛图-B，振幅分别为8.75%、8.55%、6.78%。北海康成-B公司简介：CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225094736a4c505d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225094736a4c505d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssitimber.com.hk","stockEarnings":[{"period":"1week","weight":-0.0109},{"period":"1month","weight":0.0584},{"period":"3month","weight":0.2197},{"period":"6month","weight":0.1102},{"period":"1year","weight":19},{"period":"ytd","weight":0.0625}],"compareEarnings":[{"period":"1week","weight":0.0309},{"period":"1month","weight":-0.0002},{"period":"3month","weight":-0.0129},{"period":"6month","weight":-0.0151},{"period":"1year","weight":0.252},{"period":"ytd","weight":0.0103}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"CANbridge Pharmaceuticals Inc是一家全球生物制药公司。该公司专注于罕见病转化疗法的研究、开发和商业化。该公司拥有一个药物组合，其中包括三种获批药物和八种资产的管线，针对尚未满足需求的罕见病适应症。这些包括亨特综合征和其他溶酶体贮积症、阵发性睡眠性血红蛋白尿和其他补体介导的疾病、血友病A、代谢性疾病、罕见胆汁淤积性肝病和神经肌肉疾病。其管线包括Hunterase、Livmarli、CAN106和CAN103。Hunterase是一种酶替代疗法，用于治疗II型粘多糖贮积症（MPS II），也称为亨特综合征。Livmarli是一种口服、吸收率极低、可逆性的回肠胆汁酸转运蛋白抑制剂，正在开发中，用于治疗罕见的胆汁淤积性肝病，包括Alagille综合征和进行性家族性肝内胆汁淤积症。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.126185},{"month":2,"riseRate":0.4,"avgChangeRate":0.011895},{"month":3,"riseRate":0.2,"avgChangeRate":-0.095239},{"month":4,"riseRate":0.2,"avgChangeRate":-0.008767},{"month":5,"riseRate":0,"avgChangeRate":-0.117685},{"month":6,"riseRate":0.25,"avgChangeRate":0.256405},{"month":7,"riseRate":0.5,"avgChangeRate":0.547002},{"month":8,"riseRate":0.25,"avgChangeRate":0.239858},{"month":9,"riseRate":0.75,"avgChangeRate":0.161514},{"month":10,"riseRate":0,"avgChangeRate":-0.161874},{"month":11,"riseRate":0.25,"avgChangeRate":-0.205763},{"month":12,"riseRate":0.5,"avgChangeRate":0.059277}],"exchange":"SEHK","name":"北海康成-B","nameEN":"CANBRIDGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北海康成-B,01228,北海康成-B股票,北海康成-B股票老虎,北海康成-B股票老虎国际,北海康成-B行情,北海康成-B股票行情,北海康成-B股价,北海康成-B股市,北海康成-B股票价格,北海康成-B股票交易,北海康成-B股票购买,北海康成-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}